Format

Send to

Choose Destination
Expert Opin Drug Saf. 2007 Jul;6(4):375-83.

Lithium: a novel treatment for Alzheimer's disease?

Author information

1
Indiana University School of Medicine, Department of Pediatrics, IU Medical Center, Indianapolis, IN 46202, USA. jizhong@iupui.edu

Abstract

Lithium is an alkali metal. First described as a mood stabilizer in 1949, it remains an efficacious treatment for bipolar disorders. Recent emerging evidence of its neuroprotective and neurogenic effects alludes to lithium's potential therapeutic use in stroke and neurodegenerative diseases. One intriguing clinical application is in the treatment of Alzheimer's disease. Ongoing clinical trials are evaluating lithium's abilities to lower tau and beta-amyloid levels in cerebrospinal fluid in Alzheimer's patients. This review summarizes the supporting evidence and safety profiles of lithium's use in the treatment of neurological diseases, especially Alzheimer's disease.

PMID:
17688381
DOI:
10.1517/14740338.6.4.375
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center